Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 2,931.00
+2.10 (0.07%)
Jun 1, 2026, 3:29 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 366.05 billion as of June 1, 2026. Its market cap has increased by 15.49% in one year.
Market Cap
366.05B
Enterprise Value
362.00B
Revenue
54.53B
Ranking
n/a
PE Ratio
34.68
Stock Price
2,931.00
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 366.05B, an increase of 64,595.81%. That is a compound annual growth rate of 30.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 365.78B | 5.78% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 735.28B |
| Alkem Laboratories | 657.37B |
| Glenmark Pharmaceuticals | 641.98B |
| Ipca Laboratories | 386.75B |
| Gland Pharma | 370.70B |
| Wockhardt | 330.09B |
| Emcure Pharmaceuticals | 321.54B |
| Piramal Pharma | 229.44B |